Transforming-growth-factor-beta1	NN
in	IN
sarcoidosis	NN
.	.

Transforming-growth-factor-beta	NN
(	(
TGF-beta	NN
)	)
is	VBZ
a	DT
cytokine	NN
that	WDT
promotes	VBZ
extracellular	JJ
matrix	NN
accumulation	NN
and	CC
inhibits	VBZ
matrix	NN
degradation	NN
.	.

Although	IN
the	DT
natural	JJ
course	NN
of	IN
sarcoidosis	NN
is	VBZ
usually	RB
favourable	JJ
,	,
granuloma	NN
healing	NN
in	IN
the	DT
lung	NN
may	MD
result	VB
in	IN
pulmonary	JJ
fibrosis	NN
and	CC
respiratory	JJ
impairment	NN
in	IN
some	DT
patients	NNS
.	.

In	IN
this	DT
study	NN
TGF-beta1	NN
was	VBD
evaluated	VBN
in	IN
bronchoalveolar	JJ
lavage	NN
(	(
BAL	NN
)	)
fluid	NN
and	CC
culture	NN
supernatants	NNS
of	IN
alveolar	JJ
macrophages	NNS
(	(
AM	NNP
)	)
from	IN
73	CD
patients	NNS
with	IN
biopsy-proven	JJ
sarcoidosis	NN
.	.

Disease	NN
activity	NN
was	VBD
defined	VBN
when	WRB
patients	NNS
recently	RB
developed	VBD
or	CC
increased	VBD
symptoms	NNS
(	(
cough	NN
,	,
dyspnoea	NN
,	,
systemic	JJ
symptoms	NNS
)	)
and/or	CC
demonstrated	VBD
increasing	VBG
opacities	NNS
on	IN
chest	NN
radiography	NN
.	.

Pulmonary	JJ
function	NN
tests	NNS
were	VBD
performed	VBN
in	IN
all	DT
patients	NNS
including	VBG
forced	VBN
expiratory	JJ
volume	NN
in	IN
one	CD
second	JJ
(	(
FEV1	NN
)	)
,	,
forced	VBD
vital	JJ
capacity	NN
(	(
FVC	NN
)	)
,	,
total	JJ
lung	NN
capacity	NN
(	(
TLC	NN
)	)
and	CC
the	DT
diffusing	VBG
capacity	NN
of	IN
the	DT
lung	NN
for	IN
carbon	NN
monoxide	NN
(	(
DL	NN
,	,
CO	NN
)	)
.	.

Fourteen	CD
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
and	CC
14	CD
healthy	JJ
subjects	NNS
were	VBD
investigated	VBN
as	IN
a	DT
control	NN
group	NN
.	.

Immunohistochemistry	NN
was	VBD
used	VBN
to	TO
evaluate	VB
the	DT
cell	NN
distribution	NN
of	IN
TGF-beta1	NN
on	IN
lung	NN
specimens	NNS
.	.

TGF-beta1	NN
levels	NNS
in	IN
BAL	NN
and	CC
in	IN
AM	NNP
supernatants	NNS
were	VBD
not	RB
different	JJ
between	IN
sarcoidosis	NN
and	CC
healthy	JJ
subjects	NNS
,	,
whereas	IN
they	PRP
were	VBD
markedly	RB
increased	VBN
in	IN
IPF	NN
.	.

However	RB
,	,
the	DT
TGF-beta1	NN
level	NN
was	VBD
significantly	RB
increased	VBN
in	IN
BAL	NN
fluid	NN
but	CC
not	RB
in	IN
AM	NNP
supernatants	NNS
from	IN
sarcoidosis	NN
with	IN
altered	JJ
lung	NN
function	NN
,	,
compared	VBN
with	IN
patients	NNS
with	IN
normal	JJ
lung	NN
function	NN
.	.

The	DT
TGF-beta1	NN
level	NN
in	IN
BAL	NN
was	VBD
increased	VBN
in	IN
active	JJ
sarcoidosis	NN
but	CC
this	DT
increased	VBN
level	NN
was	VBD
mainly	RB
related	JJ
to	TO
the	DT
higher	JJR
level	NN
observed	VBN
in	IN
patients	NNS
with	IN
altered	JJ
lung	NN
function	NN
.	.

TGF-beta1	NN
levels	NNS
in	IN
BAL	NN
correlated	VBD
significantly	RB
with	IN
the	DT
lymphocyte	NN
percentage	NN
.	.

TGF-beta1	NN
staining	NN
assessed	VBN
by	IN
immunohistochemistry	NN
was	VBD
intense	JJ
in	IN
epithelioid	NN
histiocytes	NNS
comprising	VBG
non-necrotizing	JJ
granuloma	NN
and	CC
in	IN
bronchiolar	JJ
epithelial	JJ
cells	NNS
,	,
in	IN
hyperplastic	JJ
type	NN
II	CD
pneumocytes	NNS
and	CC
occasionally	RB
in	IN
AM	NNP
.	.

This	DT
study	NN
supports	VBZ
the	DT
hypothesis	NN
that	IN
overproduction	NN
of	IN
transforming-growth-factor-beta1	NN
is	VBZ
associated	VBN
with	IN
functional	JJ
impairment	NN
in	IN
patients	NNS
with	IN
pulmonary	JJ
sarcoidosis	NN
.	.

